Search Results
Sep 02, 2026, 07:53 ET Cornerstone Robotics oznamuje strategické partnerstvo s Medtronic - rozšírenie globálneho prístupu k roboticky asistovanej chirurgii
pretrváva. V Cornerstone Robotics sme si vybudovali silný základ prostredníctvom komplexného interného výskumu a vývoja spolu s vertikálnou integráciou, čo nám umožňuje neustále zdokonaľovať kľúčové technológie chirurgickej robotiky. Vďaka partnerstvu s Medtronic môžeme ďalej urýchľovať a rozširovať svoju
More news about: Cornerstone Robotics
Sep 02, 2026, 07:46 ET Cornerstone Robotics объявляет о стратегическом партнерстве с Medtronic для расширения глобального доступа к роботизированной хирургии
мире.КонсультантыЮридическими консультантами Cornerstone Robotics выступают фирмы Kirkland & Ellis и Global Law Office. Morgan Stanley & Co. LLC выполняет функции эксклюзивного финансового консультанта Medtronic, а Cleary Gottlieb Steen & Hamilton LLP выступает в качестве ведущего юридического
More news about: Cornerstone Robotics
Sep 02, 2026, 07:42 ET Sceye and SoftBank Corp. przeprowadziły w Japonii demonstrację łączności ze stratosfery, stawiając kolejne kroki w kierunku komercjalizacji HAPS
operacyjne: jest na tyle blisko Ziemi, by umożliwiać łączność i obserwację o dużej przepustowości, a jednocześnie na tyle wysoko, by objąć duży obszar. Co ważne, zapewnia warunki podobne do tych panujących w przestrzeni kosmicznej bez kosztów typowych dla infrastruktury kosmicznej i bez ograniczeń działania
More news about: Sceye
Sep 02, 2026, 07:28 ET CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
adverse events were reportedProf. Dr. Uwe Zeymer, Vice Director of the Institute for Heart Attack Research in Ludwigshafen, Germany and Co-Principal Investigator of the STAR-T (Safe and Timely Antithrombotic Removal – Ticagrelor) Registry stated,
More news about: CytoSorbents Corporation
Sep 02, 2026, 07:05 ET Partillion Bioscience Expands Access to Functional Cell Analysis at the 49th Annual Course in Cytometry
attendees how existing cytometry infrastructure can support emerging applications, including secretion screening and cell-cell interaction assays." Altman co-organized the course with Carina Torres and Cheryl Kim of Cytometry Educational Associates, Inc.Lowering the Barrier to Functional Cell AnalysisNanovials
More news about: Partillion Bioscience
Sep 02, 2026, 07:05 ET Godrej Industries Group's National Chemistry Day Summit Explores Resilience as a Defining Capability for the Chemical Industry
(Chemicals) and featured Raj Tiwari, CEO, SUPERFORM and Whole-time Director, UPL Limited; Ajith Kumar, Chief Operating Officer, Birla Opus; and Vimal Bhola, Co-founder and Chief R&D Scientist, Innovist, formerly Onesto Labs.The discussion explored how organisations can build greater resilience through
More news about: Godrej Industries Group
Sep 02, 2026, 07:02 ET Futura MedTech Appoints Abhishek Bhargava as Group CEO
cardiology and electrophysiology.Beyond his corporate leadership experience, Abhishek brings an entrepreneurial perspective to his new role. He co-founded SmartMedicalBuyer.com, one of India's early digital platforms focused on medical supply procurement.An alumnus of XLRI Jamshedpur and
More news about: Futura MedTech
Sep 02, 2026, 07:01 ET Concrete Superplasticizers Market worth $10.54 billion by 2031 - Exclusive Report by MarketsandMarkets™
on capacity expansion and product launches to sustain their market position.Jiangsu Subote New Material Co., Ltd. (China), Ha-be Betonchemie GmbH (Germany), and NIPPON SHOKUBAI CO., LTD. (Japan) are considered among the other players in the concrete superplasticizers market. Download
More news about: MarketsandMarkets
Sep 02, 2026, 07:00 ET BEAM DELIVERY OPTICS ARE OPTIMIZED FOR CO₂ 10.6 µm LASERS
PROVIDENCE, R.I., Sept. 2, 2026 /PRNewswire/ -- Laser Research Optics has introduced a full line of CO2 beam delivery optics for use with lasers in the metal cutting, welding, engraving, plastic, textile, and medical industries.
More news about: Laser Research Optics
Sep 02, 2026, 07:00 ET Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
formulations. By temporarily depolymerizing hyaluronan in the extracellular matrix, ALT-B4 facilitates the rapid and efficient dispersion and absorption of co-administered therapeutics. The agreement demonstrates Novartis' commitment to innovating new options for patients and enhancing the treatment experience.
More news about: Alteogen Inc.
Sep 02, 2026, 07:00 ET Raziel Therapeutics and Fosun Pharma Announce Positive Phase 3 Results for RZL-012 in Submental Fat Reduction, Clearing the Path to a China NDA Filing
these results reinforce our confidence in RZL-012's potential to address a significant unmet need in medical aesthetics," said Phillip Cui, Co-CEO of Fosun Health Capital. About RZL-012 RZL-012 is an injectable lipolytic drug in development for the reduction of unwanted
More news about: Raziel Therapeutics; Fosun Pharma
Sep 02, 2026, 07:00 ET CREDIT ONE BANK ANNOUNCES "CREDIT TIP OFF TOUR" HOSTED BY "CREDIT PROFESSOR" SHAQUILLE O'NEAL TO BRING FREE CREDIT EDUCATION & DJ SETS TO COLLEGES
creator, has built her platform by bringing fans closer to the world of sports through engaging interviews, commentary and social content. Dumoulin, co-founder of The School of Hard Knocks, has built a following of tens of millions through conversations with successful entrepreneurs about the
More news about: Credit One Bank
Sep 02, 2026, 06:59 ET Khushi Kapoor and Cava Come Together to Create Soft Serve, Her Dream Athleisure Collection
happens when an actor known for her effortless personal style gets to create the athleisure wardrobe she actually wants to wear? Soft Serve, a co-created collection by Khushi Kapoor and Cava, brings together Khushi's personal approach to fashion with Cava's expertise in performance-led athleisure.
More news about: Cava Athleisure
Sep 02, 2026, 06:59 ET Pilot-Operated Gas Regulators Market worth $0.52 billion by 2031 | MarketsandMarkets™
offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the
More news about: MarketsandMarkets
Sep 02, 2026, 06:45 ET Aitan Emerges from Stealth, Defines New Defense Category of Robotic Sovereignty-as-a-Service -- Closes $41 Million Funding Round to Scale Its Battle-Proven Technology Globally
Latest financing round co-led by Deep33 and Dell Technologies Capital brings total capital raised to $54 millionAitan's frontier autonomy and robotic warfare technology arms allied nations with sovereign robotic combat power NEW YORK,
More news about: Aitan
Sep 02, 2026, 06:30 ET Vertiv Announces Agreement to Acquire UtilityInnovation Group to Accelerate Time to Power for AI Data Centers
architecturesCOLUMBUS, Ohio, Sept. 2, 2026 /PRNewswire/ -- Vertiv Holdings Co. (NYSE: VRT) ("Vertiv"), a global leader in critical digital infrastructure, today announced its wholly-owned subsidiary, Vertiv Corporation, has entered
More news about: Vertiv Holdings Co
Sep 02, 2026, 06:00 ET Vertiv Declares Quarterly Dividend
COLUMBUS, Ohio, Sept. 2, 2026 /PRNewswire/ -- Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today announced that its Board of Directors has declared a quarterly cash dividend of $0.0625
More news about: Vertiv Holdings Co
Sep 02, 2026, 06:00 ET NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
to advancing the clinical development program together with NovaGo Therapeutics and our co-investors, with generous support from the Swiss Paraplegic Foundation and Wings for Life.""We are very pleased to co-lead this financing and support NovaGo's next stage of development. The progress and results
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
to advancing the clinical development program together with NovaGo Therapeutics and our co-investors, with generous support from the Swiss Paraplegic Foundation and Wings for Life.""We are very pleased to co-lead this financing and support NovaGo's next stage of development. The progress and results
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET MS Transverse Appoints Three New Members to Board of Directors
in April 2026 after nearly 40 years in the industry, most recently serving as U.S. Vice Chairman of Aon Reinsurance Solutions. He previously served as Co-President of Aon's U.S. Reinsurance business, overseeing more than 900 colleagues, and held leadership roles on Aon Reinsurance's global executive committee
More news about: MS Transverse Insurance Group
Sep 02, 2026, 06:00 ET NovaGo Therapeutics schließt Serie-B-Finanzierungsrunde in Höhe von 30 Millionen US-Dollar ab, um die Proof-of-Concept-Studie bei akuter Rückenmarksverletzung voranzutreiben
vielversprechenden Phase-1-Ergebnissen mit NG004 sehr ermutigt und freuen uns darauf, das klinische Entwicklungsprogramm gemeinsam mit NovaGo Therapeutics und unseren Co-Investoren sowie mit großzügiger Unterstützung der Schweizer Paraplegiker-Stiftung und von Wings for Life voranzutreiben.".„Wir freuen uns sehr,
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics clôture un tour de financement de série B de 30 millions de dollars américains pour faire avancer son étude de validation de principe sur les lésions médullaires aiguës
phase 1 avec le NG004, et nous avons hâte de poursuivre le programme de développement clinique en collaboration avec NovaGo Therapeutics et nos co-investisseurs, grâce au généreux soutien de la Fondation suisse pour paraplégiques et de Wings for Life. »« Nous sommes très heureux de codiriger ce tour
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET Delistings Trend Below Last Year's Pace As Summer Comes to an End: Realtor.com® August Housing Report
-0.8Denver-Aurora-Centennial, CO2.1 %
More news about: Realtor.com
Sep 02, 2026, 05:20 ET TwinDEX Introduces a Scalable Path from Robot-Free Data Collection to Real-World Dexterous Manipulation
SHENZHEN, China, Sept. 2, 2026 /PRNewswire/ -- Today, X Square Robot introduced TwinDEX, a pair of co-designed, three-finger, nine-DoF dexterous manipulation interface: one wearable for data collection, one for robot deployment. Together with synchronized
More news about: X Square Robot
Sep 02, 2026, 05:00 ET Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
https://www.prnewswire.com/news-releases/norroy-bioscience-initiates-pivotal-phase-iii-clinical-trial-of-177lu-nym032-a-psma-targeted-radioligand-therapy-for-mcrpc-302867430.htmlSOURCE Norroy Bioscience Co., Ltd.
More news about: Norroy Bioscience Co., Ltd.